CannabisNewsBreaks – Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) Enters MOU to Complete Cannabis Cultivation Facility Buildout

Isracann Biosciences (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF), an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, on Tuesday announced its entrance into a memorandum of understanding (“MOU”) for a joint venture (“JV”) with a late stage cannabis farm in Israel. The JV is intended to complete a late stage buildout of a cannabis cultivation facility in an agricultural center proximal to several licensed producers (“LP’s”) west of Be’er Sheva, Israel (the “Be’er Sheva Farm”). Pursuant to the JV, Isracann will capitalize the buildout of the remaining construction in exchange for an economic interest in the project in compliance with Israeli laws. Following the signing of a definitive agreement, which is subject to continued due diligence of the Be’er Sheva Farm by Isracann, the terms of the joint venture will be released. “We’ve been evaluating several opportunities to expedite our commercialization plans and based on my inspection of the property this farm offers the ability to shorten our time-to-market. The fundamentals are already in place, including building permits, and the basic infrastructure is already constructed which accelerates timing. Once we conclude our due diligence efforts, the proposed plan will be to advance the technical efforts including completion of the greenhouse and concurrently implementing a project characterization strategy in preparation to planting. There is still a lot of work to complete, but our efforts at our Nir Israel farm have already provided us with regional business relationships, experienced advisors, and extensive preparations that we can readily extend and implement across both locations,” Isracann VP Operations Matt Chatterton stated in the news release.

To view the full press release, visit http://cnw.fm/1IIlb

About Isracann Biosciences Inc.

Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel’s agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. The company has secured agreements within Israel for medicinal marijuana cultivation. For more information, visit the company’s website at www.Isracann.com.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands Distribution to New Markets

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced expansion of Canadian distribution to all ten provinces, with select brands to be available in Québec and Newfoundland and Labrador. According to the update, Supreme Cannabis entered into a letter of intent with Société Québécoise du Cannabis (“SQDC”) to supply 7ACRES products to retail stores across Québec. The company, on November 21, 2019, also entered into a formal agreement to supply the Newfoundland and Labrador Liquor Corporation (“NLC”) with 7ACRES high-end cultivars. “With increased packaging capacity we are pleased to have the recreational supply necessary to serve new consumers in Québec and Newfoundland and Labrador. As we enter two new provinces, we continue to benefit from the strength of our experienced sales team,” Supreme Cannabis CEO Navdeep Dhaliwal said in the news release. “In anticipation of our 7ACRES brand entering these priority provinces, we specifically launched strains with east coast consumers in mind.”

To view the full press release, visit http://cnw.fm/Qv8ec

About Supreme Cannabis Company

The Supreme Cannabis Company, Inc., is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. Supreme Cannabis’ portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco, a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Sugarleaf by 7AC, crafted for the convenient pleasure of the cannabis experience; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada. Supreme trades as FIRE on the Toronto Stock Exchange (TSX: FIRE), SPRWF on the OTC Exchange in the United States (OTCQX: SPRWF) and 53S1 on the Frankfurt Stock Exchange (FRA: 53S1). Follow the company on Instagram, Twitter, Facebook and YouTube. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/FIRE

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Prices $5.58M Series D Cumulative Redeemable Perpetual Preferred Stock Offering

Youngevity International (NASDAQ: YGYI, YGYIP), a leading multi-channel lifestyle company, today announced the pricing of its underwritten public offering of 245,398 shares of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock at a price to the public of $22.75 per share. Youngevity expects approximately $5.58 million in gross proceeds from the offering, from which it intends to use the net proceeds for working capital and other general corporate purposes. The closing of the offering, subject to the satisfaction of customary conditions, is expected to occur on or about December 20, 2019. The shares of Series D Preferred Stock trade on the Nasdaq Capital Market under the symbol “YGYIP” and will not be convertible into or exchangeable for any of the company’s other securities. The Benchmark Company, LLC is acting as sole book-running manager of the offering.

To view the full press release, visit http://cnw.fm/SAyZ4

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI, YGYIP), is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – MLB Action Prompts Stakeholders to Expect a Marijuana Policy Shift in the NFL

Toward the end of last week, a top National Football League (NFL) team owner, Jerry Jones, and the New England Patriots quarterback player, Tom Brady, said that the league’s marijuana rules are bound to change after the MLB announced that it is eliminating marijuana from the list of banned substances for baseball players.

In an on-air interview with a Dallas radio station on Friday, Jones said that any issue regarding marijuana is a sensitive topic across the globe. He also noted that the leagues are excited about the possibility of being at par with the social and legal scene on marijuana.

Jones observed that they are not only looking at the issue of competitiveness when it comes to substance usage but also the law, as well as the societal focus on marijuana. It is also an important issue to discuss with the players.

In an on-air interview with Westwood One Sports on Thursday, Brady said that the MLB move to remove marijuana is a sign that times are changing, and progress is good.

Brady further said that there has been rumors that the NFL is going to follow in the MLB’s footsteps. He noted that the stigma against marijuana is being eradicated. Brady also added that he is hoping that before a decision is made, they will research the benefits that will ensue from the move.

Currently, the NFL teams and players associations are negotiating on a collective bargaining agreement; this will give the owners a chance to change the rules on drug testing and punishment.

Brady said that he does not know much about the issue, but he is sure there are experts present to provide them with advice.

Jones has always been against the NFL’s strict stance on marijuana. A recent survey on cannabis showed that 67% of Americans are in favor of marijuana legalization. Punishing players for consuming cannabis could be more harmful to the NFL public image than do any good.

In the annual drugs test, if an NFL player’s results are positive, several fines are imposed, suspension and rehabilitation, whereas a contracted player can be tested at a minimum notice of 3 hours. In 2018, the NFL collected $4,000,000 in fines due to positive drug tests.

Speaking to Los Angeles Times, the former Chargers offensive lineman Kyle Turley said that players are known to side-step the process, passing annual marijuana tests, and then smoking weed the rest of the year. Baseball is a brutal game, and marijuana could help other players as it saved his life.

Speaking to The Washington Post in October, sources close to league owners said that the owners are willing to amend marijuana policies by making them less punitive, and this would limit NFL Commissioner Roger Goodell’s disciplinary powers over cannabis. The league and union are willing to study how pot can be used to manage pain.

Currently, the NFL team owners and NFL players’ unions are negotiating, and neither of the parties can comment on their progress. Past agreement negotiations lasted for a period of 57 days.

According to experts, this possible policy shift is likely to be good news for cannabis industry players like Neutra Corp. (OTC: NTRR) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) who have always wanted all categories of people to enjoy the benefits of marijuana, especially for medicinal purposes.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Senators Pressure DEA to Provide Update on Cannabis Grower Applications

Top federal drug and health agencies are under pressure from a group of senators to provide an update about the long overdue increase in the number of authorized marijuana manufacturers for study purposes.

Led by Senator Elizabeth Warren (D-MA), the lawmakers wrote a letter emphasizing the importance of expanding the supply of research-grade marijuana as more states move to legalize marijuana either for recreational or medical consumption. The letter was addressed to the Drug Enforcement Administration (DEA), Office of National Drug Control Policy, and the Department of Health and Human Services.

Although the DEA announced that it would approve additional marijuana growers for research-grade weed more than three years ago, it is yet to deliver on its promise since it keeps delaying the process. In August the agency said that it is in the process of approving the applications; however, due to the large number of applications, it will have to establish alternative rules before issuing new permits.

The DEA made that announcement before the deadline issued by the court previously, which required the agency to take action. The lawsuit against the DEA was filed by a researcher whose application for marijuana production for research purposes had been suspended. The court dismissed the suit in October since the agency provided an update.

However, the senators were not placated by the agency’s response, and they are seeking guidance on the process to be taken to ensure that the qualified researchers are granted licenses on time.

The letter which was sent on Wednesday last week said that the number of studies covering the therapeutic effects of cannabis is limited even though millions of U.S. citizens are legally permitted to consume medical or recreational marijuana. The letter further noted that the number of Americans seeking doctors’ advice on marijuana treatment for ailments, such as chronic pain, PTSD, or terminal illnesses is ever-growing; therefore, federal agencies should make an effort to increase the amount of credible information on marijuana health benefits and health risks.

Being classified under Schedule 1 of the Controlled Substances Act creates a barrier for researchers to conduct studies on marijuana.

The lawmakers also argued in the letter that inhibiting research opportunities and discouraging researchers who are independent and qualified from conducting studies on the benefits of marijuana is a hindrance to states looking to implement their marijuana laws. Marijuana studies are vital to developing an understanding of marijuana, and the findings would be a gem to the doctors, patients, and lawmakers across the U.S.

The letter also poses five questions to the agencies, and they expected the response by January 10.

The status and timeline of application approval by the DEA
Information about the existing supply of research-grade marijuana and if the facility is cultivating more varieties.
Information on whether the government would reschedule marijuana
The application process guidelines.
Their support for research on the therapeutic effects of marijuana

The senators also wrote that there is a need for evidence-based public policy, which is vital to securing the health of the citizens since millions of Americans can now access medical and recreational marijuana. They added that the federal government should provide the necessary leadership and tools required in developing research in cannabis.

Other senators who signed the letter include Ron Wyden (D-OR), Kristen Gillibrand (D-NY), Cory Booker (D-NJ), Ed Markey (D-MA), and Jacky Rosen (D-NV).

To what extent will such letters result in tangible results on the regulatory front? Experts cannot be certain that marijuana companies like Dama Financial and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) are still keeping count of the different letters that have been written to the federal authorities on matters of marijuana policy reform since the feds seem to be working based on their own schedule.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – How Marketing and PR Strategies Help CBD Brands Stand Out Amidst Tight Competition

USA CBD Expo recently published an article on the rapid growth of the cannabidiol (“CBD”) industry, as well as tips on capturing a share of the market amidst uncertainty and tight competition. The article discussed the need for both startups and established brands to deploy a mix of marketing and public relations strategies to truly stand out from competitors. Discussing the advantages of engaging PR firms and newswire services, the article reads, “Public relations strategies remain one of the most effective ways available for cannabis brands to gain recognition and reach new audiences. Consistent placements in the media can greatly accelerate growth. The sole purpose of media relations is to inform current and potential consumers, stakeholders, investors, partners, and employees of your company while convincing them to maintain a positive view of cannabis companies and the industry as a whole. A strong media relations strategy helps eliminate poor publicity, spreads the word to individuals who haven’t heard of you yet, and promotes growth.”

To view the full article, visit http://cnw.fm/Wim9S

About USA CBD Expo

USA CBD Expo strives to create the best and largest CBD / Hemp event in the nation, to consistently bring the most innovative and best products/brands to businesses and consumers, to compress a rapidly expanding industry into one all-encompassing, premier event. The USA CBD Expo team is committed to representing our unrivaled passion in our events, and is dedicated to presenting the benefits of CBD, a product it truly believes in. The work culture is what sets us apart from the rest. While it is passionate about crafting the best event, the USA CBD Expo couldn’t do it without its love for what it does. The people that work at the offices have a genuine care for the finished product and work tirelessly each day to ensure every show delivers its trademark of premium quality. USA CBD Expo is committed to maximizing efficiency when it comes to finding an exact fit for you and your business. Whether you’re a buyer, a business, or a consumer, you will find everything you need at one of the shows. With 300+ vendors- the right product, the right brand, and the right deal will be available all at once, only at the Nation’s Largest CBD Event. For more information, visit www.USACBDExpo.com

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – MCTC Holdings, Inc. (MCTC) Featured in Exclusive Audio Interview to Discuss Strategy, Plans for Exotic Cannabinoids

MCTC Holdings (OTC: MCTC), doing business as Cannabis Global Inc., today announced the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. During the interview, Cannabis Global Chairman and CEO Arman Tabatabaei discussed the Company’s strategy to take advantage of opportunities in the cannabis industry while avoiding overcrowded market niches. “The area we are targeting is the middle part of the market, specifically the post-processing of the refined hemp and cannabis products,” Tabatabaei said in the interview. “Our aim is to take refined products, such as isolates and distillates, and process those technologies via our enhanced product into more advanced products that can be sold through food, beverage and consumer brands. We are doing this through a science-based approach, and we have already filed five patents that are pending in these areas.”

To listen to the interview, visit http://cnw.fm/HO9Cu

To view the full press release, visit http://cnw.fm/K9Fxi

About MCTC Holdings, Inc.

MCTC Holdings, doing business as Cannabis Global Inc., is focused on delivering long-term shareholder growth and results. The company invests with confidence and determination to be the forefront of the cannabis and CBD revolution. For more information, visit the company’s website at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Democrats in Congress Cede to Senate’s Position on Veteran-Related Marijuana Provisions

Democrats in Congress have abandoned two marijuana proposals that were veteran-based and previously approved by Congress as part of their large-scale defense bill.

The House approved its version of the National Defense Authorization Act (NDAA) this summer. The legislation had several changes that would prevent the United States Department of Veteran Affairs from denying the veterans’ home loans applications due to their employment status in the legal marijuana sector.

The bill had another policy that would have allowed the military branches to reenlist service members convicted of single simple marijuana offenses.

However, the Senate did not have similar proposals in their legislation, but the leaders from the two bodies agreed to scrap some of the additional policies during the negotiations.

The Democrats did not cede on all the amendments that were not similar to the House legislation; but, both parties made compromises on the amendment proposals where the House withdrew about 630 provisions while the Senate ceded approximately 600.

The House conference negotiators did not view the marijuana measure as a priority. However, according to the sponsors of the bill, marijuana policies were to be prioritized as they represented urgent needs for the veterans and service members.

The home loan amendment provisions were made by Rep. Katherine Clark (D-MA). In May, Clark circulated a sign-on letter addressed to Veteran Affairs. The letter raised the issue and noted that a veteran in her district was denied home loan benefits because he was working in the marijuana industry.

The reenlistment waiver proposal was sponsored by Rep. Ruben Gallego (D-AZ). During a committee hearing in June, Gallego stressed that the country needs to think about military enlistment policies regarding marijuana felonies, especially looking at the recruitment crisis.

Gallego further said that the country’s views on marijuana consumption are changing, and the military has adjusted its recruitment process. He also noted that where necessary, the military can grant waivers to former simple marijuana convicts who want to serve their country.

According to a summary of the legislation, the House conference negotiators agreed on a bill funding “drug interdiction and counter-drug activities” by giving them $1 billion. The bill also calls for an assessment of the impact of any planned border wall construction would have on the quantity of narcotics entering the U.S. The bill includes the Fentanyl Sanctions Act, which puts in place several economic and financial sanctions to cease the operation of international opioid traffickers.

It is uncertain if the House Democrats will fight for the marijuana reform language in the appropriations negotiations. The current temporary spending legislation expires on December 20, and their goal is to finalize the full 2020 Fiscal Year appropriation before the expiration date.

In June, Rep. Earl Blumenauer (D-OR) withdrew a policy that would have permitted Veteran Affairs to prescribe medical marijuana to military veterans during the House consideration of the VA appending bill.

Analysts believe that cannabis industry actors, such as HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), may not be too pleased that veterans will continue to be victimized for their involvement in state-legal marijuana programs.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Poll Finds Most Kansas Residents in Favor of Marijuana Legalization

A new survey carried out by Fort Hays State University in Kansas shows that the majority of the state’s residents are in favor of recreational marijuana, and they are in support of the industry’s taxation.

The Annual Kansas Speaks survey used opinions of Kansas residents on a myriad of public policy issues such as Medicaid expansion and weapons control. The report, which was released last week, revealed that more than 63% of the participants are in support of legalizing and taxing adult-use marijuana.

About 26% of the respondents are opposed to marijuana legalization efforts, while 11% of the participants were neutral on marijuana law reform.

Although support for marijuana legalization is backed by the majority of the state’s electorate, marijuana remains illegal even for medical use. However, marijuana may be legalized in the state of Kansas in the near future.

Lawmakers in Kansas took the first steps in advancing the marijuana reform in October. Ohio’s medical marijuana program limits the patients to a 90-day supply and also bans smoking of weed. The Special Committee on Federal and State Affairs requested the legislature to benchmark Ohio’s medical marijuana program. They also included the prohibition of vaping medical marijuana in the legalization proposal.

Senator Oletha Faust-Goudea (D) said that the legislation is bound to pass, and it is their responsibility to sit at the negotiation table and perfect the law to serve the people better.

Governor Laura Kelly (D) also said that she is in favor of medical marijuana.

Local towns and cities in Kansas are also moving forward with marijuana reform. Lawrence City Commission, for example, suggested a decrease in the criminal charges for possessing small amounts of weed to a fine of $1 and $63 in court costs. The motion garnered 4-1 votes in favor of the ordinance, which applies to first and second convictions. Third level offenses are felonies, and they cannot be processed in municipal court.

Lawrence Mayor, Lisa Larsen, said that the move by the city’s leaders was initiated to keep unwarranted charges off the city’s residents’ legal records.

She further said that her motive is to bring some reasonable and equitable justice to the people of Lawrence City.

According to a news release, the Kansas Speaks survey was conducted through phone interviews, whereby the researchers interviewed 352 residents from the month of August 26 to October 14, 2019. The study is the state’s only yearly research of Kansas residents’ views on issues relating to public affairs. The survey margin of error was 5.2%, with a 95% accuracy level.

It would be interesting to hear what marijuana companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and SinglePoint Inc. (OTCQB: SING) think about the results of this poll and the provisions of the legalization bill.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – MCTC Holdings, Inc. (MCTC) Releases CEO Shareholder Letter, Strategic Direction for 2020

MCTC Holdings (OTC: MCTC) today provided a letter to its shareholders to recap 2019 and provide an overview of the company’s plans moving into 2020. Among the topics covered, the letter discussed the company’s reorganization with a new management team led by Arman Tabatabaei, as well as installation of an experienced board of directors. The letter also covered the company’s current strategic direction to re-position in the cannabinoid sciences arena. “It is our team’s strong belief that one of the most underserved submarkets of the hemp and cannabis marketplaces relates to the delivery of hemp extracts and cannabinoids to the human body. The Farm Bill of 2018, which made hemp legal at the federal level, is now one year old. Prior to this time, it had generally been illegal for scientists and researchers to possess hemp extracts, thus there had been very little research accomplished,” MCTC CEO Arman Tabatabaei stated in the letter. “The passage of the Farm Bill has now opened up numerous areas of research for MCTC, and others, to pursue relative to developing the best methods and sciences relating to administering hemp extracts and cannabinoids to the human body. We have hit the ground running in the area, which is generally being identified as the cannabinoid sciences sub-sector of the cannabis and hemp marketplaces.”

To view the full press release, visit http://cnw.fm/GS7rw

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.